Human platelet lysate is derived from platelets of healthy human donors by freezing and thawing platelet units. It serves as a substitute to fetal bovine serum as a growth supplement for cell culture models. It minimizes risks associated with animal serum and provides highly defined and standardized growth conditions. The market is growing due to the increasing adoption of human platelet lysate as an alternative to fetal bovine serum as it provides more consistent cell cultures without the risks of animal-derived products or ethical issues. It is finding widespread usage in cell therapy, gene therapy, regenerative medicines, and 3D cell culture models.

The global Human Platelet Lysate Market is estimated to be valued at US$ 61.06 Billion in 2023 and is expected to exhibit a CAGR Of 9.4% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights

Human platelet lysate finds applications in therapeutic areas such as wound healing, cellular therapy, tissue engineering, and cancer research. It enhances the growth of human mesenchymal stem cells, endothelial cells, and fibroblasts and is therefore used in therapeutics involving stem cell therapies, gene therapies, and regenerative medicines. It can also accelerate the healing of acute wounds and chronic leg ulcers. Due to exceptional growth benefits for various human cell types, human platelet lysate is increasingly replacing animal serum in clinical-grade cell culture processes. It minimizes the risk of transmittable unknown viruses or prions present in animal-derived products. The global human platelet lysate market is expected to be flourished by the growing adoption of regenerative medicines and stem cell therapies where human platelet lysate serves as a key raw material.

Market Dynamics:

The two main drivers aiding the growth of the human platelet lysate market include the increasing adoption of regenerative medicines and stem cell therapies and human platelet lysate serving as a safer alternative to fetal bovine serum. Regenerative medicines involving stem cell therapies have demonstrated efficacy in treating chronic diseases such as cardiovascular diseases, neurological disorders, and autoimmune diseases. The development of off-the-shelf allogeneic stem cell therapies is further driving the demand for raw materials such as human platelet lysate. Additionally, human platelet lysate provides inconsistent benefits over fetal bovine serum as a growth supplement for various human cell types in vitro. It eliminates risks of transmitting unknown prions or viruses from bovine or other animal sources, providing highly standardized and defined growth conditions for cell cultures. This is increasing its adoption as the preferred growth supplement.

Segment Analysis

The global human platelet lysate market is segmented into application and end user. Based on application, the market is segmented into research use and therapeutic use. Among these, the research use segment dominated the market in 2021 and is estimated to witness high growth during the forecast period owing to the growing applications of human platelet lysates in the research of regenerative medicines and stem cell culture. The therapeutic use segment is also expected to witness steady growth driven by increasing applications of human platelet lysate in therapies like wound healing and skin grafting.

PEST Analysis

Political: Governments across countries are supporting research in regenerative medicine and stem cell therapy which is positively impacting the growth of the human platelet lysate market.

Economic: Rising healthcare expenditure coupled with increasing R&D investments in pharmaceutical and biotechnology industries are fueling the market growth.

Social: Increasing awareness about tissue engineering and regenerative therapies among patients is driving the demand for human platelet lysates.

Technological: Advancements in lyophilization techniques for platelet lysate production are helping companies improve the quality and shelf life of platelet lysate products. Continuous developments are further expanding the applications of platelet lysates.

Key Takeaways

The Global Human Platelet Lysate Market Demand is expected to witness high growth over the forecast period.

Regional analysis indicates that North America dominates the market currently owing to presence of major market players and considerable research activities in the field of regenerative medicine. Europe is also a major regional market driven by high healthcare spending and supportive government initiatives.

Key players operating in the human platelet lysate market are Air Methods Corporation, Deccan Charters, Scandinavian Air Ambulance, Air Ambulance Specialists, Air Charter Service, Envision Healthcare Companies, Falck Danmark A/S, AMR Air Ambulance, AirMed International, Express Aviation Services, and ALPHASTAR. Key players are focused on expanding their product portfolios and geographical presence through mergers & acquisitions and partnerships with research institutes.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it